An observational study in Appendicitis, sponsored by University of British Columbia. Completed at 1 site in Canada. Per ClinicalTrials.gov, last updated 2011-06-03.
Sponsored by University of British Columbia · Observational
There is a move to "scarless surgery" and this achieved by doing laparoscopic abdominal surgery though a single small umbilical incision. A technique for laparoscopic appendectomy done through a single incision utilizing conventional instruments has been developed. The operative risk of the single incision approach is no different that the standard three incision laparoscopic appendectomy. The goal is to study the operative time, length of hospital stay, and complications from this operation.
412 studies on the registry are indexed under Appendicitis; 62 are open to participants now.
This study's planned enrollment of 32 is below the median of 200 across 150 observational studies indexed under Appendicitis.
Browse Appendicitis studies →University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
All patients presenting to a community hospital (RGH) with a working diagnosis of acute appendicitis when the investigator (myself) and co-investigator (Dr. Bloom) are on call for general surgery emergencies.
Exclusion Criteria:
Procedure: Single Incision Laparoscopic Appendectomy
This study is completed, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of British Columbia